Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chembiochem : a European Journal of Chemical Biology|October 6, 2009
Amphiphilic counterion activators for DNA: stimuli-responsive cation transporters and biosensors in bulk and lipid bilayer membranesToshihide Takeuchi, Valentina Bagnacani, Francesco Sansone, et al.
ACS Chemical Biology|September 6, 2014
Toward peptide nucleic acid (PNA) directed peptide translation using ester based aminoacyl transferAbhishek Singhal, Valentina Bagnacani, Roberto Corradini, et al.
Organic Letters|August 30, 2008
Macrocyclic nonviral vectors: high cell transfection efficiency and low toxicity in a lower rim guanidinium calix[4]areneValentina Bagnacani, Francesco Sansone, Gaetano Donofrio, et al.
The Journal of Organic Chemistry|April 16, 2011
CO2 capture by multivalent amino-functionalized calix[4]arenes: self-assembly, absorption, and QCM detection studiesLaura Baldini, Monica Melegari, Valentina Bagnacani, et al.
Nature Communications|April 18, 2013
Arginine clustering on calix[4]arene macrocycles for improved cell penetration and DNA deliveryValentina Bagnacani, Valentina Franceschi, Michele Bassi, et al.
Bioconjugate Chemistry|April 3, 2012
Lower rim guanidinocalix[4]arenes: macrocyclic nonviral vectors for cell transfectionValentina Bagnacani, Valentina Franceschi, Laura Fantuzzi, et al.
Frontiers in Pharmacology|March 29, 2024
CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powderCataldo Martucci, Andrew Dennis Allen, Nadia Moretto, et al.
Frontiers in Pharmacology|November 11, 2024
Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powderCataldo Martucci, Andrew Dennis Allen, Nadia Moretto, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic windowGino Villetti, Chiara Carnini, Loredana Battipaglia, et al.
Journal of Medicinal Chemistry|December 5, 2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory DiseasesLaura Carzaniga, Gabriele Amari, Andrea Rizzi, et al.
Pageof 2